RHYTHM PHARMACEUTICALS, INC. Depreciation and Amortization
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Depreciation and Amortization of $500.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-02-26
- RHYTHM PHARMACEUTICALS, INC. depreciation, depletion and amortization for the quarter ending 2021-12-31 was -$17.00K, a 109.55% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. depreciation, depletion and amortization for the quarter ending 2021-09-30 was $315.00K, a 83.14% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. depreciation, depletion and amortization for the quarter ending 2021-06-30 was $317.00K, a 83.24% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. depreciation, depletion and amortization for the quarter ending 2021-03-31 was $201.00K, a 20.36% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. depreciation, depletion and amortization for fiscal 2025 was $500.00K, a 28.57% decline from fiscal 2024.
- RHYTHM PHARMACEUTICALS, INC. depreciation, depletion and amortization for fiscal 2024 was $700.00K, a 22.22% decline from fiscal 2023.
- RHYTHM PHARMACEUTICALS, INC. depreciation, depletion and amortization for fiscal 2023 was $900.00K, a 0.45% increase from fiscal 2022.
- RHYTHM PHARMACEUTICALS, INC. depreciation, depletion and amortization for fiscal 2022 was $896.00K, a 9.80% increase from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month | Depreciation, Depletion and Amortization 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $500.00K 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | $700.00K 10-K · filed 2026-02-26 | $710.00K 10-K · filed 2025-02-28 | |||
| 2023-12-31 | $900.00K 10-K · filed 2026-02-26 | $903.00K 10-K · filed 2024-02-29 | |||
| 2022-12-31 | $896.00K 10-K · filed 2025-02-28 | ||||
| 2021-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $298.00K derived: sum of 2 quarters · filed 2024-02-29 | $615.00K derived: sum of 3 quarters · filed 2024-02-29 | $816.00K 10-K · filed 2024-02-29 | |
| 2021-09-30 | $315.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $632.00K derived: sum of 2 quarters · filed 2021-11-02 | $833.00K 10-Q · filed 2021-11-02 | $1.01M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $317.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $518.00K 10-Q · filed 2021-08-03 | $696.00K derived: sum of 3 quarters · filed 2023-03-01 | $868.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $201.00K 10-Q · filed 2021-05-03 | $379.00K derived: sum of 2 quarters · filed 2023-03-01 | $551.00K derived: sum of 3 quarters · filed 2023-03-01 | $724.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $350.00K derived: sum of 2 quarters · filed 2023-03-01 | $523.00K derived: sum of 3 quarters · filed 2023-03-01 | $690.00K 10-K · filed 2023-03-01 | |
| 2020-09-30 | $172.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $345.00K derived: sum of 2 quarters · filed 2021-11-02 | $512.00K 10-Q · filed 2021-11-02 | $703.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $340.00K 10-Q · filed 2021-08-03 | $531.00K derived: sum of 3 quarters · filed 2022-03-01 | $722.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $167.00K 10-Q · filed 2021-05-03 | $358.00K derived: sum of 2 quarters · filed 2022-03-01 | $549.00K derived: sum of 3 quarters · filed 2022-03-01 | $756.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $382.00K derived: sum of 2 quarters · filed 2022-03-01 | $589.00K derived: sum of 3 quarters · filed 2022-03-01 | $834.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $398.00K derived: sum of 2 quarters · filed 2020-11-02 | $643.00K 10-Q · filed 2020-11-02 | $857.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $452.00K 10-Q · filed 2020-08-03 | $666.00K derived: sum of 3 quarters · filed 2021-03-01 | $772.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $245.00K 10-Q · filed 2020-05-04 | $459.00K derived: sum of 2 quarters · filed 2021-03-01 | $565.00K derived: sum of 3 quarters · filed 2021-03-01 | $626.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $320.00K derived: sum of 2 quarters · filed 2021-03-01 | $381.00K derived: sum of 3 quarters · filed 2021-03-01 | $442.00K 10-K · filed 2021-03-01 | |
| 2018-09-30 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $167.00K derived: sum of 2 quarters · filed 2019-11-01 | $228.00K 10-Q · filed 2019-11-01 | $288.00K derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $122.00K 10-Q · filed 2019-07-29 | $182.00K derived: sum of 3 quarters · filed 2020-03-02 | $237.00K derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $61.00K 10-Q · filed 2019-05-03 | $121.00K derived: sum of 2 quarters · filed 2020-03-02 | $176.00K derived: sum of 3 quarters · filed 2020-03-02 | $230.00K derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $115.00K derived: sum of 2 quarters · filed 2020-03-02 | $169.00K derived: sum of 3 quarters · filed 2020-03-02 | $223.00K 10-K · filed 2020-03-02 | |
| 2017-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $109.00K derived: sum of 2 quarters · filed 2018-11-09 | $163.00K 10-Q · filed 2018-11-09 | $218.00K derived: sum of 4 quarters · filed 2019-03-08 | |
| 2017-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $108.00K 10-Q · filed 2018-08-08 | $163.00K derived: sum of 3 quarters · filed 2019-03-08 | ||
| 2017-03-31 | $54.00K 10-Q · filed 2018-05-14 | $109.00K derived: sum of 2 quarters · filed 2019-03-08 | |||
| 2016-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $144.00K 10-K · filed 2019-03-08 | |||
| 2016-09-30 | $89.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |